Expert RA upgraded PROMOMED DM's credit rating to ruA
27.04.2022
27.04.2022
The company is interested in scientific cooperation and student exchange with universities in Uzbekistan. This was stated by Dmitry Zemskov, Executive Director of Biochemik JSC, during a round table organized by the Ministry of Industry and Trade of the Russian Federation, "Partnership between Russia and Uzbekistan in the pharmaceutical and medical industry sector", on April 26 in Tashkent.

The speaker shared his experience as one of the largest pharmaceutical manufacturers in the Russian Federation, the Biochemist plant, cooperates with various universities in the country, and as an example spoke about cooperation with the Ogarev Mordovian State University. Over the years, the company and the university have developed strong partnerships. The result of fruitful work was the Department of Chemistry and Technology of Physiologically Active Substances, founded on the basis of the enterprise in 2018. Every year, the university trains up to 30 specialists for the needs of the plant. In addition, joint programs on education, research activities, production practice of students and training of plant employees on the basis of educational institutions are being successfully implemented. The relevant experience is planned to be extended to universities in Uzbekistan.
"We are ready to consider cooperation with Uzbek universities on exchange programs and joint scientific work," Dmitry Zemskov said, "And we are also interested in accepting Uzbek students for internship with further employment in our company, or with the return of qualified specialists to the pharmaceutical industry of Uzbekistan."
JSC Biochemist already has an international practice of experience exchange. During the Soviet years, students from India, Syria, Iran and other countries learned the intricacies of pharmaceutical production.
Stay informed
Stay informed
Get the most interesting news and publications first!
Sent successfully!
Press office
To request a press release or interview, please contact our press office